|
SE9504661D0
(sv)
|
1995-12-22 |
1995-12-22 |
Astra Pharma Inc |
New compounds
|
|
US6974825B1
(en)
|
1996-12-20 |
2005-12-13 |
Astrazeneca Canada Inc. |
Compounds with analgesic effect
|
|
TW548271B
(en)
|
1996-12-20 |
2003-08-21 |
Astra Pharma Inc |
Novel piperidine derivatives having an exocyclic double bond with analgesic effects
|
|
SE9604786D0
(sv)
|
1996-12-20 |
1996-12-20 |
Astra Pharma Inc |
New compounds
|
|
EP1512683B1
(en)
*
|
1998-03-10 |
2011-08-31 |
Research Triangle Institute |
Novel opiate compounds, methods of making and methods of use
|
|
US6900228B1
(en)
|
1998-03-10 |
2005-05-31 |
Research Triangle Institute |
Opiate compounds, methods of making and methods of use
|
|
JP2003500392A
(ja)
*
|
1999-05-25 |
2003-01-07 |
セプラコール， インク． |
複素環式鎮痛性化合物およびその使用方法
|
|
US6635661B2
(en)
|
2000-05-25 |
2003-10-21 |
Sepracor Inc. |
Heterocyclic analgesic compounds and methods of use thereof
|
|
US7361666B2
(en)
|
1999-05-25 |
2008-04-22 |
Sepracor, Inc. |
Heterocyclic analgesic compounds and methods of use thereof
|
|
US6677332B1
(en)
|
1999-05-25 |
2004-01-13 |
Sepracor, Inc. |
Heterocyclic analgesic compounds and methods of use thereof
|
|
US6645980B1
(en)
|
2000-05-25 |
2003-11-11 |
Sepracor Inc. |
Heterocyclic analgesic compounds and methods of use thereof
|
|
SE9904674D0
(sv)
|
1999-12-20 |
1999-12-20 |
Astra Pharma Inc |
Novel compounds
|
|
SE9904673D0
(sv)
*
|
1999-12-20 |
1999-12-20 |
Astra Pharma Inc |
Novel compounds
|
|
SE9904675D0
(sv)
*
|
1999-12-20 |
1999-12-20 |
Astra Pharma Inc |
Novel compounds
|
|
JP2003518119A
(ja)
*
|
1999-12-22 |
2003-06-03 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
４−［アリール（８−アザビシクロ［３．２．１］オクタン−３−イル）］アミノ安息香酸誘導体
|
|
SE0001208D0
(sv)
*
|
2000-04-04 |
2000-04-04 |
Astrazeneca Canada Inc |
Novel compounds
|
|
SE0001209D0
(sv)
|
2000-04-04 |
2000-04-04 |
Astrazeneca Canada Inc |
Novel compounds
|
|
SE0001207D0
(sv)
|
2000-04-04 |
2000-04-04 |
Astrazeneca Canada Inc |
Novel compounds
|
|
US6887876B2
(en)
|
2000-12-14 |
2005-05-03 |
Ortho-Mcneil Pharmaceutical, Inc. |
Benzamidine derivatives
|
|
IL155995A0
(en)
|
2000-12-15 |
2003-12-23 |
Astrazeneca Ab |
New process for the preparation of diaryl-4-amino-piperidinyl compounds
|
|
US6699890B2
(en)
*
|
2000-12-22 |
2004-03-02 |
Memory Pharmaceuticals Corp. |
Phosphodiesterase 4 inhibitors
|
|
US7205320B2
(en)
|
2001-01-22 |
2007-04-17 |
Memory Pharmaceuticals Corp. |
Phosphodiesterase 4 inhibitors
|
|
US7153871B2
(en)
|
2001-01-22 |
2006-12-26 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
|
|
MXPA03007261A
(es)
*
|
2001-02-14 |
2006-03-09 |
Abbott Lab |
Moduladores del receptor de glucocorticoides.
|
|
SE0101773D0
(sv)
|
2001-05-18 |
2001-05-18 |
Astrazeneca Ab |
Novel compounds
|
|
DK1395567T3
(da)
|
2001-05-18 |
2009-04-06 |
Astrazeneca Ab |
4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser
|
|
SE0101769D0
(sv)
|
2001-05-18 |
2001-05-18 |
Astrazeneca Ab |
Novel compounds
|
|
SE0101766D0
(sv)
|
2001-05-18 |
2001-05-18 |
Astrazeneca Ab |
Novel compounds
|
|
SE0101765D0
(sv)
|
2001-05-18 |
2001-05-18 |
Astrazeneca Ab |
Novel compounds
|
|
SE0101771D0
(sv)
|
2001-05-18 |
2001-05-18 |
Astrazeneca Ab |
Novel compounds
|
|
SE0101768D0
(sv)
|
2001-05-18 |
2001-05-18 |
Astrazeneca Ab |
Novel compounds
|
|
SE0101770D0
(sv)
|
2001-05-18 |
2001-05-18 |
Astrazeneca Ab |
Novel compounds
|
|
SE0103313D0
(sv)
|
2001-10-03 |
2001-10-03 |
Astrazeneca Ab |
Novel compounds
|
|
EP1539697A1
(en)
|
2002-07-19 |
2005-06-15 |
Memory Pharmaceutical Corporation |
Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
|
|
RU2354648C2
(ru)
|
2002-07-19 |
2009-05-10 |
Мемори Фармасьютиклз Корпорейшн |
Соединения 6-амино-1н-индазола и 4-аминобензофурана в качестве ингибиторов фосфодиэстеразы 4
|
|
ATE387443T1
(de)
|
2002-10-15 |
2008-03-15 |
Janssen Pharmaceutica Nv |
Substituierte aminochinuclidin verbindungen und deren verwendung als delta-opioid rezeptor liganden
|
|
WO2004035541A1
(en)
*
|
2002-10-15 |
2004-04-29 |
Janssen Pharmaceutica, N.V. |
Benzyl substituted (piperidin-4-yl) aminobenzamido derivatives as delta-opiod receptor modulators
|
|
SE0203302D0
(sv)
|
2002-11-07 |
2002-11-07 |
Astrazeneca Ab |
Novel Compounds
|
|
SE0203303D0
(sv)
|
2002-11-07 |
2002-11-07 |
Astrazeneca Ab |
Novel Compounds
|
|
SE0203300D0
(sv)
|
2002-11-07 |
2002-11-07 |
Astrazeneca Ab |
Novel Compounds
|
|
AU2003295656B2
(en)
|
2002-11-19 |
2010-11-11 |
Memory Pharmaceuticals Corporation |
Pyridine N-oxide compounds as phosphodiesterase 4 inhibitors
|
|
EP1613597B1
(en)
|
2003-03-07 |
2007-11-07 |
Eli Lilly and Company |
6-substituted nicotinamide derivatives as opioid receptor antagonists
|
|
US7589103B2
(en)
|
2003-06-27 |
2009-09-15 |
Janssen Pharmaceutica N.V. |
Tricyclic-bridged piperidinylidene derivatives as 8-opioid modulators
|
|
CA2549009A1
(en)
*
|
2003-12-12 |
2005-07-07 |
Eli Lilly And Company |
Opioid receptor antagonists
|
|
EP1735268B1
(en)
|
2004-03-15 |
2012-02-15 |
Eli Lilly And Company |
Opioid receptor antagonists
|
|
DK1781631T3
(da)
|
2004-08-02 |
2012-05-14 |
Astrazeneca Ab |
Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf
|
|
EP1910353A1
(en)
|
2004-08-05 |
2008-04-16 |
Janssen Pharmaceutica N.V. |
Tricyclic delta- opioid modulators
|
|
SE0402485D0
(sv)
|
2004-10-13 |
2004-10-13 |
Astrazeneca Ab |
Polymorph of N,N-Diethyl-4-(3-Fluorophenyl-Piperidin-4-Ylidene-Methyl)-Benzamide Hydrochloride salt
|
|
ATE432279T1
(de)
|
2004-12-22 |
2009-06-15 |
Janssen Pharmaceutica Nv |
Tricyclische delta-opioid-modulatoren
|
|
JP2008525483A
(ja)
|
2004-12-22 |
2008-07-17 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
三環式δ−オピオイド調節剤
|
|
KR20070104380A
(ko)
|
2005-01-06 |
2007-10-25 |
얀센 파마슈티카 엔.브이. |
트리사이클릭 δ-오피오이드 조절제
|
|
ATE490251T1
(de)
|
2005-06-16 |
2010-12-15 |
Janssen Pharmaceutica Nv |
Tricyclische opioidmodulatoren
|
|
JP2007099761A
(ja)
*
|
2005-09-08 |
2007-04-19 |
Mitsui Chemicals Inc |
アミド誘導体ならびにその殺虫剤としての使用方法
|
|
MY148880A
(en)
|
2006-10-20 |
2013-06-14 |
Astrazeneca Ab |
N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression
|
|
JP5781527B2
(ja)
*
|
2009-10-30 |
2015-09-24 |
ヤンセン ファーマシューティカ エヌ．ベー． |
４−置換−２−フェノキシ−フェニルアミンデルオピオイド受容体調節因子
|
|
CN113979997A
(zh)
*
|
2021-11-12 |
2022-01-28 |
中国科学院昆明植物研究所 |
N,n-(4-哌啶基、芳基)-3-氨基苯酚类衍生物及其药物组合物和其应用
|